Your browser doesn't support javascript.
loading
Poly(ADP-ribose) Polymerase Inhibitor Combinations in First-Line Metastatic Castration-Resistant Prostate Cancer: Increasing Toxicity With Unclear Benefits.
Madan, Ravi A; Karzai, Fatima; VanderWeele, David J; Cheng, Heather H; de Bono, Johann S.
Affiliation
  • Madan RA; Genitourinary Malignancies Branch, National Cancer Institute, Bethesda, MD.
  • Karzai F; Genitourinary Malignancies Branch, National Cancer Institute, Bethesda, MD.
  • VanderWeele DJ; Division of Hematology/Oncology, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL.
  • Cheng HH; Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA.
  • de Bono JS; The Institute of Cancer Research, London, United Kingdom.
J Clin Oncol ; 41(36): 5501-5504, 2023 Dec 20.
Article in En | MEDLINE | ID: mdl-37847874
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms, Castration-Resistant / Antineoplastic Agents Limits: Humans / Male Language: En Journal: J Clin Oncol Year: 2023 Document type: Article Affiliation country: Moldova
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms, Castration-Resistant / Antineoplastic Agents Limits: Humans / Male Language: En Journal: J Clin Oncol Year: 2023 Document type: Article Affiliation country: Moldova